ライフサイエンスコーパス: peripheral blood lymphocyte

1 ytes; high-load carriers, >200 genomes/10(5) peripheral blood lymphocytes).

2 abundant (>1% of total MHC-I transcripts in peripheral blood lymphocytes).

3 th determination of basal H(2)O(2) levels in peripheral blood lymphocytes.

4 erosis have been largely confined to testing peripheral blood lymphocytes.

5 pithelial cells, T lymphocyte cell lines, or peripheral blood lymphocytes.

6 ons (including dicentrics and ring forms) in peripheral blood lymphocytes.

7 ed similar results using RNA interference in peripheral blood lymphocytes.

8 expressed RE transcripts between the OFC and peripheral blood lymphocytes.

9 thelial lymphocytes and on a small subset of peripheral blood lymphocytes.

10 approximately 30 cells/microl) of the total peripheral blood lymphocytes.

11 apoptosis were compared in elephant vs human peripheral blood lymphocytes.

12 ing receptor profile similar to untransduced peripheral blood lymphocytes.

13 2ME2 does not reduce the survival of normal peripheral blood lymphocytes.

14 tacrolimus were studied using purified human peripheral blood lymphocytes.

15 ic genotypes after costimulation of cultured peripheral blood lymphocytes.

16 e-B lymphoma L1.2 cells, Jurkat T cells, and peripheral blood lymphocytes.

17 re sufficiently high to induce chemotaxis of peripheral blood lymphocytes.

18 n measurements in surrogate tissues, such as peripheral blood lymphocytes.

19 d p16 mutations identified in DNA from their peripheral blood lymphocytes.

20 ct persistent LCV infection in rhesus monkey peripheral blood lymphocytes.

21 fluids, including serum, saliva, urine, and peripheral blood lymphocytes.

22 the VHL-gene mutation in a portion of their peripheral blood lymphocytes.

23 , cpm-1285 had little effect on normal human peripheral blood lymphocytes.

24 and is observed predominantly in testis and peripheral blood lymphocytes.

25 l-free assays and viral replication in human peripheral blood lymphocytes.

26 ponse to IL-2 in both T-cell lines and human peripheral blood lymphocytes.

27 mune-deficient mice reconstituted with human peripheral blood lymphocytes.

28 sequences are transcriptionally abundant in peripheral blood lymphocytes.

29 uman endogenous retrovirus was isolated from peripheral blood lymphocytes.

30 f CD4+CD25+ T cells when cultured with human peripheral blood lymphocytes.

31 lymphocyte co-cultures between normal human peripheral blood lymphocytes, (1) frequencies of memory

32 ave been observed to be induced in activated peripheral blood lymphocytes, a cell type relevant to HI

33 d blood lymphocytes (CBL) compared to adult (peripheral) blood lymphocytes (ABL).

34 s by injecting inferior lacrimal glands with peripheral blood lymphocytes activated by 5 days of cocu

35 Autologous peripheral blood lymphocytes, activated in a mixed-cell

36 >40 cases of primary cells, including normal peripheral blood lymphocytes, acute lymphoblastic leukem

37 ns and in the tissue culture supernatants of peripheral blood lymphocytes after stimulation.

38 ho developed persistent virus loads in their peripheral blood lymphocytes after transplantation.

39 units/106 cells) was documented in quiescent peripheral blood lymphocytes after treatment initiated b

40 t Vbeta restriction was found using the same peripheral blood lymphocytes against a different haploty

41 trate different, but stable, levels of donor peripheral blood lymphocyte and granulocyte chimerism.

42 Peripheral blood lymphocyte and urine DNA obtained from

43 shortening in CHD is restricted to specific peripheral blood lymphocyte and/or myeloid cell subpopul

44 e intracellular growth of M. tuberculosis by peripheral blood lymphocytes and antigen-specific CD4+ T

45 rferon enzyme-linked immunospot assays using peripheral blood lymphocytes and autologous CD1(+) immat

46 envelope-specific gamma interferon-secreting peripheral blood lymphocytes and better priming of T-cel

47 Infections of peripheral blood lymphocytes and certain cell lines were

48 rotein levels are induced in activated human peripheral blood lymphocytes and CycT1 protein levels ar

49 Serum and CVL were incubated with normal peripheral blood lymphocytes and HIV-1 gp120-bearing tar

50 we observed that exposure in vitro of normal peripheral blood lymphocytes and human bone marrow-deriv

51 ere isolated 1 year postoperatively from the peripheral blood lymphocytes and iliac crest bone marrow

52 fibronectin induced Vav1 phosphorylation in peripheral blood lymphocytes and in two different T cell

53 on, yields enhanced rolling ligands for both peripheral blood lymphocytes and Jurkat cells in flow ch

54 Tat delayed FasL-mediated apoptosis in both peripheral blood lymphocytes and Jurkat cells, as it is

55 Phenotypic analysis of peripheral blood lymphocytes and mixed lymphocyte reacti

56 We have found that treatment of peripheral blood lymphocytes and purified resting CD4(+)

57 ved from phytohemagglutinin (PHA) stimulated peripheral blood lymphocytes and radiation hybrid mappin

58 his hypothesis, we obtained matched pairs of peripheral blood lymphocytes and serum specimens simulta

59 Analyses of peripheral blood lymphocytes and serum suggested that PO

60 AW and PW enhanced HIV infection of peripheral blood lymphocytes and T-cell lines (Jurkat an

61 xtent, IL-7 enhance the expression of A3G in peripheral blood lymphocytes and that this effect is blo

62 Both the mean frequencies of donor-reactive peripheral blood lymphocytes and the number of individua

63 nduction of neuropeptide substance P in both peripheral blood lymphocytes and the T-cell lines.

64 ound to be expressed on the surface of human peripheral blood lymphocytes and transformed B- and T-ly

65 Flow cytometry was used to analyze peripheral-blood lymphocytes and bone marrow aspirates.

66 rapy, rabbit ATG is more potent in depleting peripheral-blood lymphocytes and is preferred in other c

67 deficient mice were reconstituted with human peripheral blood lymphocytes, and encephalitis was induc

68 ere defined arbitrarily as >25 spots/300,000 peripheral blood lymphocytes, and positive PRT was defin

69 nts of infection, including the oral cavity, peripheral blood lymphocytes, and the cell-free fraction

70 Peak in vivo levels of genetically modified peripheral blood lymphocytes approached 35% +/- 22% (n =

71 NY-ESO-1 was used to transduce CD8-depleted peripheral blood lymphocytes as antigen-presenting cells

72 -Hodgkin's lymphoma (NHL), but not in normal peripheral blood lymphocytes as well as in nonmalignant

73 The results demonstrated that human peripheral blood lymphocytes as well as mouse spleen lym

74 nd gag sequences were PCR amplified from the peripheral blood lymphocytes available from 9 of the 10

75 were measured, and the activation status of peripheral blood lymphocytes bearing mucosal homing mark

76 infusions in sIBM patients depletes not only peripheral blood lymphocytes but also endomysial T cells

77 of normal human thyroid cells and in 21% of peripheral blood lymphocytes, but only in 6% of normal m

78 We examined the phenotype and function of peripheral blood lymphocytes by cell surface or intracel

79 d CD8+ T cells expressing cytokines waned in peripheral blood lymphocytes by day 84, but CD8+ T cell

80 ssion of the early activation marker CD69 in peripheral blood lymphocytes by flow cytometry may provi

81 evels of LOXL1 were determined on c-DNA from peripheral blood lymphocytes by quantitative real-time R

82 (TIL 1383I) and introduced into normal human peripheral blood lymphocytes by retroviral transduction.

83 DNA damage was assessed on peripheral blood lymphocytes by the comet assay before a

84 atedly stimulated with irradiated allogeneic peripheral blood lymphocytes caused the strongest inhibi

85 In contrast, in peripheral blood lymphocytes, CCR9(+) lymphocytes were m

86 Peripheral blood lymphocyte chimerism (WF/ACI) remained

87 CD8(+) set is readily detected in the human peripheral blood lymphocyte compartment, particularly du

88 ation, oxidative stress, and their impact on peripheral blood lymphocyte composition.

89 rface expression on normal B cells or on any peripheral blood lymphocytes could be detected.

90 , we investigated whether PD-1 expression on peripheral blood lymphocytes could be used as a biomarke

91 0 mg/day produced a significant reduction in peripheral blood lymphocyte count by up to 85%, which re

92 Median CD4+, CD8+, and CD19+ peripheral blood lymphocyte counts at 73-84 months after

93 Ex vivo analysis of peripheral blood lymphocytes demonstrated enhanced CD16

94 l-characterized breast cell line HCC1395 and peripheral blood lymphocytes derived from the same patie

95 sites such as dorsal root ganglion neurons, peripheral blood lymphocytes, developing thymocytes, and

96 fluorescent InsB10-23:DQ8 tetramers, stained peripheral blood lymphocytes directly ex vivo, and show

97 the marrow at neuroblastoma diagnosis or in peripheral blood lymphocyte DNAs of six normal subjects.

98 A. actinomycetemcomitans and DCs to cultured peripheral blood lymphocytes elicited high levels of IFN

99 lines, as well as Sezary Syndrome patients' peripheral blood lymphocytes, exhibited ratio-dependent

100 Peripheral blood lymphocytes express CCR5, a chemokine r

101 on with IL-12/IL-18, monocyte-depleted human peripheral blood lymphocytes expressed the 79-kDa form o

102 We show that, in Jurkat human T cells and peripheral blood lymphocytes, Fas-induced apoptosis is p

103 demonstrate up-regulation of JAM3 protein on peripheral blood lymphocytes following activation.

104 etection of interleukin-2 receptor on 97% of peripheral blood lymphocytes for 30-45 days.

105 rable engraftment at levels exceeding 10% of peripheral blood lymphocytes for at least 2 months after

106 ) were seen during ITx rejection in archived peripheral blood lymphocyte from test and replication co

107 genes, was used to examine serial samples of peripheral blood lymphocytes from 11 adult patients with

108 Each of 2 aliquots of peripheral blood lymphocytes from 4 rhesus monkeys were

109 Peripheral blood lymphocytes from 41 hemodialysis patien

110 Mutagen sensitivity was measured in peripheral blood lymphocytes from 460 individuals [148 p

111 -gamma ELISPOT and cytotoxicity assays using peripheral blood lymphocytes from 66 HBV-infected patien

112 l RNA isolated from Tat- and vehicle-treated peripheral blood lymphocytes from a healthy donor showed

113 of CD4(+) T-cell clones were generated from peripheral blood lymphocytes from a patient with a nonpr

114 generation and DNA damage, freshly prepared peripheral blood lymphocytes from all three groups were

115 ing of Tax11-19/HLA-A*0201 tetramer-positive peripheral blood lymphocytes from an HTLV-1-infected ind

116 by PCR-based genome walking using uncultured peripheral blood lymphocytes from an HTLV-3-infected per

117 CTL activity to allogeneic paternal cells in peripheral blood lymphocytes from both horse mares and d

118 dendritic cells (DCs) were used to stimulate peripheral blood lymphocytes from cervical cancer patien

119 The extent of endogenous DNA damage in peripheral blood lymphocytes from dogs given the dietary

120 Short-term cultured peripheral blood lymphocytes from each subject were expo

121 Peripheral blood lymphocytes from elephants, healthy hum

122 s between human leukocyte antigen-mismatched peripheral blood lymphocytes from healthy adults.

123 mRNA TCR engineering of peripheral blood lymphocytes from healthy donors or chro

124 al lipids was analyzed in ex vivo studies of peripheral blood lymphocytes from human patients with pu

125 ified beta-galactosidase and showed that the peripheral blood lymphocytes from in utero-transduced sh

126 Here, we used fresh peripheral blood lymphocytes from individual subjects un

127 tained behavioural data, plasma samples, and peripheral blood lymphocytes from individuals living in

128 and breast cancer cell lines, as well as by peripheral blood lymphocytes from lymphoma patients, can

129 during T-cell receptor-mediated apoptosis in peripheral blood lymphocytes from normal donors.

130 r cells (CD34+) and interleukin-2-stimulated peripheral blood lymphocytes from normal healthy donors

131 assessed the functional responses to IFN in peripheral blood lymphocytes from patients with 3 major

132 ine deaminase (ADA) cDNA to transduce mature peripheral blood lymphocytes from patients with ADA defi

133 ponses against six cancer-testis antigens in peripheral blood lymphocytes from patients with esophage

134 (2) and its possible effect on DNA damage in peripheral blood lymphocytes from patients with vitiligo

135 iated lysis (range: 52-100% inhibition) when peripheral blood lymphocytes from seven healthy donors,

136 After CD3/CD28 activation, peripheral blood lymphocytes from SSc patients produced

137 8 beads with higher frequency than activated peripheral blood lymphocytes from the same patients.

138 Peripheral blood lymphocytes from these subjects were an

139 No peripheral blood lymphocytes from three HLA-2.1+ donors

140 In vitro assays demonstrated that peripheral blood lymphocytes from tolerant animals produ

141 tramer-binding CD8+ T cells were detected in peripheral blood lymphocytes from two of six patients af

142 However, routine peripheral blood lymphocyte gamma interferon enzyme-link

143 nduced by mutagens in short-term cultures of peripheral blood lymphocytes, has been used as an indire

144 d (low-load carriers, 8 to 200 genomes/10(5) peripheral blood lymphocytes; high-load carriers, >200 g

145 ility and genome damage in the primary human peripheral blood lymphocytes (HPBLs) and exhibited free

146 efficacy in HIV-1-infected humanized [human peripheral blood lymphocyte (Hu-PBL)] mice by completely

147 icient mice that were repopulated with human peripheral blood lymphocytes (hu-PBL-NOD/SCID mice).

148 d immunodeficient murine recipients of human peripheral-blood lymphocytes (hu-PBL-SCID).

149 acute allograft dysfunction, mitogen-induced peripheral blood lymphocyte IFN-gamma:IL-5 ratios > or =

150 The genome-scale DNA methylation profiles of peripheral blood lymphocytes in cows with S. aureus subc

151 nses were quantitated using freshly isolated peripheral blood lymphocytes in direct lytic assays as w

152 mph node compartments was similar to that in peripheral blood lymphocytes in individual monkeys.

153 Proliferation of healthy donor peripheral blood lymphocytes in response to IL-2 was inh

154 f relying on immunological measurements from peripheral blood lymphocytes in studies of protective im

155 and could be transmitted from macrophages to peripheral blood lymphocytes in trans 6 weeks after ongo

156 quinone-mediated DNA damage by estrogens in peripheral blood lymphocytes in vitiligo.

157 To address this issue, we irradiated human peripheral blood lymphocytes in vitro with 0.5 Gy densel

158 upregulation of tetherin (BST-2 or CD317) on peripheral blood lymphocytes, including the CD4(+) CCR5(

159 Depletion of peripheral blood lymphocytes, including the naive and me

160 us is frequently detected in squirrel monkey peripheral blood lymphocytes, indicating that persistent

161 The cytotoxicity for human peripheral blood lymphocytes is extremely low (>100 muM)

162 ssociated loss of telomere length in vivo in peripheral blood lymphocytes is specific to T and B cell

163 y various mutagens in short-term cultures of peripheral blood lymphocytes, is an established risk fac

164 n immediate depletion or severe reduction of peripheral blood lymphocytes, lasting at least 6 months.

165 xicity of dexamethasone against nonmalignant peripheral blood lymphocytes, mesenchymal stromal cells,

166 rm of MIP-1 beta secreted by activated human peripheral blood lymphocytes (MIP-1 beta(3-69)) lacks th

167 t lengths and FMR1 mRNA expression levels in peripheral blood lymphocytes, motor functioning, and whi

168 We found that human peripheral blood lymphocytes not only provide lytic sign

169 le-chain Fv (scFv) antibody library from the peripheral blood lymphocytes of 20 patients with various

170 al instability, we used FISH to evaluate the peripheral blood lymphocytes of 22 PBSC donors and 22 ma

171 , HTLV-I tax sequence was amplified from the peripheral blood lymphocytes of 4 of them.

172 a measure of recent thymic emigrant cells in peripheral blood lymphocytes of 50 HIV-infected infants

173 and markedly decreased protein expression in peripheral blood lymphocytes of affected patients.

174 ng motif, was used to generate CTLs from the peripheral blood lymphocytes of an HLA-A1+ healthy donor

175 essful heterohybridoma immortalized from the peripheral blood lymphocytes of an infertile woman who e

176 NY-ESO-1-specific CD8+ and CD4+ T cells from peripheral blood lymphocytes of cancer patients in vitro

177 ome; we identified 2410 integration sites in peripheral blood lymphocytes of five infected individual

178 CD30(+) T lymphocytes were increased in peripheral blood lymphocytes of melanoma patients at adv

179 the interpretation of measurements made with peripheral blood lymphocytes of multiple sclerosis patie

180 type and Th2-type CD4+ T-cell responses from peripheral blood lymphocytes of normal donors and melano

181 inducing specific CD4+ T cells in vitro from peripheral blood lymphocytes of normal donors and patien

182 I) Tax11-19 peptide-specific CD8(+) cells in peripheral blood lymphocytes of patients with HTLV-I-ass

183 Spleens, lymph nodes, and peripheral blood lymphocytes of secondary tolerant recip

184 substitutions in variable VH6 genes from the peripheral blood lymphocytes of three patients with xero

185 e target DNA sequences as small as 50 nts in peripheral blood lymphocytes or in stretched DNA fibers.

186 id tumors, accessible normal tissues such as peripheral blood lymphocytes or, perhaps more germane to

187 enriched TILs had significantly fewer CD4(+) peripheral blood lymphocytes (P = .01).

188 In peripheral blood lymphocytes, papain cleaved off HLA cla

189 erforming genomewide bisulfite sequencing in peripheral blood lymphocyte (PBL) and hair follicle DNA

190 2) standard miniature swine; and 3) GalT-KO peripheral blood lymphocytes (PBL) and cultured endothel

191 ssed by an interferon gamma ELIspot assay in peripheral blood lymphocytes (PBL) and in a lymph node d

192 ercent of mice with >20% of CD4+ cells among peripheral blood lymphocytes (PBL) by 13 weeks posttrans

193 tion of IFN by phytohemagglutinin-stimulated peripheral blood lymphocytes (PBL) compared to Edmonston

194 SAHA in CTCL cell lines and freshly isolated peripheral blood lymphocytes (PBL) from CTCL patients wi

195 colonic lamina propria lymphocytes (LPL) and peripheral blood lymphocytes (PBL) from healthy individu

196 When responding peripheral blood lymphocytes (PBL) from normal volunteer

197 nes (MJ, Hut78, and HH) and freshly isolated peripheral blood lymphocytes (PBL) from SS patients with

198 DNA PCR levels, defined as >/=40 genomes/105 peripheral blood lymphocytes (PBL) in pretransplant EBV-

199 CR for imprinting analysis of IGF2 on normal peripheral blood lymphocytes (PBL) of individuals.

200 omic sequences are readily detectable in the peripheral blood lymphocytes (PBL) of seropositive indiv

201 ared the characteristics of fresh RCC TIL to peripheral blood lymphocytes (PBL) or melanoma TIL.

202 The reduced ability of Vgamma2Vdelta2(+) peripheral blood lymphocytes (PBL) to expand could be re

203 We found that treatment of peripheral blood lymphocytes (PBL) with methyl-beta-cycl

204 ance between CTL activity in lymph nodes and peripheral blood lymphocytes (PBL), CTL specific for sim

205 ve been successfully treated with autologous peripheral blood lymphocytes (PBL), genetically modified

206 CR3 expressed in recombinant cells and human peripheral blood lymphocytes (PBL).

207 ) enzyme-linked immunospots (ELISPOTS)/10(6) peripheral blood lymphocytes (PBL).

208 ileum, mesenteric lymph nodes [MLN], spleen, peripheral blood lymphocytes [PBL], and bone marrow lymp

209 specimens (6 PBC and 6 controls), and fresh peripheral blood lymphocytes (PBLs) (10 PBC and 10 contr

210 sma (n = 59) by TaqMan PCR and in samples of peripheral blood lymphocytes (PBLs) (n = 60) by competit

211 cks to the early phase of HIV-1 infection in peripheral blood lymphocytes (PBLs) and a B lymphocytic

212 or-promoting phorbol ester, on primary human peripheral blood lymphocytes (PBLs) and assessed its abi

213 ominant-negative form of CDK9 (HA-dnCDK9) in peripheral blood lymphocytes (PBLs) and other cells.

214 secreted from activated human monocytes and peripheral blood lymphocytes (PBLs) as a heterodimer.

215 icted in phytohemagglutinin (PHA)-stimulated peripheral blood lymphocytes (PBLs) but proceeded effici

216 13+ (IL-13+) T cells (CD4+ or CD8+) in human peripheral blood lymphocytes (PBLs) can respond directly

217 were examined by mRNA transfection of human peripheral blood lymphocytes (PBLs) derived from healthy

218 Peripheral blood lymphocytes (PBLs) from healthy donors

219 firm the specific expression of T-plastin in peripheral blood lymphocytes (PBLs) from SS patients and

220 Peripheral blood lymphocytes (PBLs) from systemic lupus

221 nsplant patient who developed KS and in whom peripheral blood lymphocytes (PBLs) had been prospective

222 nyl-coenzyme A carboxylase (PCC) activity in peripheral blood lymphocytes (PBLs) is a sensitive indic

223 In the peripheral blood lymphocytes (PBLs) of a separate group

224 Infection of CCR5(-) human peripheral blood lymphocytes (PBLs) showed that 2 differ

225 Baseline studies were performed on peripheral blood lymphocytes (PBLs) vs. marrow in normal

226 le gene expression in human T cells, primary peripheral blood lymphocytes (PBLs) were nucleofected wi

227 Peripheral blood lymphocytes (PBLs) were treated in vitr

228 responses generated in vitro against patient peripheral blood lymphocytes (PBLs) with those detected

229 Thus, in human peripheral blood lymphocytes (PBLs), approximately 1-4%

230 can be successfully reconstituted with human peripheral blood lymphocytes (PBLs), but rates and level

231 However, for human peripheral blood lymphocytes (PBLs), this is generally r

232 Y-ESO-1-specific CD8(+) T cells derived from peripheral blood lymphocytes (PBLs), tumor-infiltrating

233 althy subjects express <1 NKT cell per 1,000 peripheral blood lymphocytes (PBLs), we devised a new me

234 rnal-beam ionizing radiation-induced DSBs in peripheral blood lymphocytes (PBLs).

235 potent CD4+ T-cell antigens, using patients' peripheral blood lymphocytes (PBLs).

236 respectively by PMA and PHA in primary human peripheral blood lymphocytes (PBLs).

237 ing both a test substrate (casein) and fresh peripheral blood lymphocytes (PBLs).

238 a ELIspot assay (Chiron, Emeryville, CA), in peripheral-blood lymphocytes (PBLs) and in a lymph node

239 tumors and phosphorylation of ERK (pERK) in peripheral-blood lymphocytes (PBLs) before and after 1 m

240 Lesional skin biopsy specimens and peripheral blood lymphocyte phenotype were analyzed.

241 ive SLE and to correlate these findings with peripheral blood lymphocyte phenotypes.

242 , SOCE measurements, immunologic analysis of peripheral blood lymphocyte populations by using flow cy

243 pansion of both rabbit splenocytes and human peripheral blood lymphocytes, preferentially expanded hu

244 CCR5 internalization, and individuals whose peripheral blood lymphocytes produce high levels of thes

245 prisingly exhibit increased bioactivity in a peripheral blood lymphocyte proliferation assay.

246 odulatory functions, specifically suppressed peripheral blood lymphocyte proliferation, induced expre

247 T helper (interleukin-5- and -10-producing) peripheral blood lymphocytes reactive with a panel of sy

248 stration of the prodrug 14 induces sustained peripheral blood lymphocyte reduction in rats.

249 Normal human peripheral blood lymphocytes resisted salinomycin toxici

250 n combination with flow cytometry to compare peripheral blood lymphocyte responses of cattle with sub

251 Flow cytometry of peripheral blood lymphocytes revealed dramatic efflux of

252 In vitro experiments with human peripheral blood lymphocytes revealed that pirfenidone r

253 ll three PCR assays gave negative results on peripheral blood lymphocyte samples from 69 humans, as w

254 Matched urine and peripheral blood lymphocyte samples were obtained before

255 for coreceptor switch variants in the human peripheral blood lymphocyte-SCID mouse model.

256 va, rectal brushings, rectal swab specimens, peripheral blood lymphocytes, semen, and urine) from hum

257 -17D-induced clones could be identified from peripheral blood lymphocytes solely by measuring clonal

258 ction, prospectively collected cryopreserved peripheral-blood lymphocyte specimens (n = 90) from the

259 TBX21 expression was detected in peripheral blood lymphocytes, spleen, lung, and natural

260 meras showed deletion of donor-reactive CD4+ peripheral blood lymphocytes, splenocytes, and mature th

261 ymphocyte reaction (MLR) responses of normal peripheral blood lymphocytes stimulated with irradiated

262 interleukin(IL)-2 expression by normal human peripheral blood lymphocytes stimulated with phorbol 12-

263 (TCR)/CD3 complex in either Jurkat cells or peripheral blood lymphocytes stimulates phosphorylation

264 s identified within certain Vbeta-expressing peripheral blood lymphocyte subpopulations in the infect

265 Peripheral blood lymphocyte subsets were analyzed by flo

266 compared their gene expression profiles and peripheral blood lymphocyte subsets with those of subjec

267 can also be conveyed from NHOKs to activated peripheral blood lymphocytes, suggesting a potential rol

268 shown to be mosaic for the FLN1 mutation in peripheral blood lymphocytes, suggesting that some neuro

269 es apoptosis in CLL cells, but not in normal peripheral blood lymphocytes, suggesting the involvement

270 ent mice reconstituted with 50 x 10(6) human peripheral blood lymphocytes) that received three biweek

271 nse to oral prednisolone, and sensitivity of peripheral blood lymphocytes to corticosteroids were mea

272 DNA cells, the dendritic cells primed normal peripheral blood lymphocytes to generate effector T cell

273 e alpha1 helix, were presented by autologous peripheral blood lymphocytes to induce T-cell proliferat

274 igen-presenting cells, we stimulated patient peripheral blood lymphocytes to isolate peptide-specific

275 culosis strain H37Rv in which the ability of peripheral blood lymphocytes to limit intracellular grow

276 er, we analyzed their expression patterns in peripheral blood lymphocytes using Pacific Biosciences (

277 , immortalized B-cells, cultured T-cells and peripheral blood lymphocytes using reverse transcriptase

278 fication of genomic DNA from miniature swine peripheral blood lymphocytes, using primers correspondin

279 in reaction (PCR), and protein expression in peripheral blood lymphocytes was analyzed by flow cytome

280 or T-cell response, the T-cell repertoire of peripheral blood lymphocytes was assessed by complementa

281 r expression on CD4+,CD28- T cell clones and peripheral blood lymphocytes was assessed by multicolor

282 Reactivation of the rMd5DeltaMeq virus from peripheral blood lymphocytes was reduced, suggesting tha

283 Peripheral blood lymphocytes were analysed by flow cytom

284 Peripheral blood lymphocytes were analysed by flow cytom

285 telomere length and telomerase expression in peripheral blood lymphocytes were analyzed from 121 norm

286 Peripheral blood lymphocytes were collected at the time

287 Viral loads >200 genome copies/10(5) peripheral blood lymphocytes were considered consistent

288 Peripheral blood lymphocytes were cultured for 90 hours,

289 Sequentially collected peripheral blood lymphocytes were examined with a recent

290 e who were seropositive) genome copies/10(5) peripheral blood lymphocytes were felt to identify patie

291 Rat PMNs and peripheral blood lymphocytes were isolated by density ce

292 Peripheral blood lymphocytes were isolated from 117 stab

293 Peripheral blood lymphocytes were isolated, ethanol-fixe

294 Fresh human peripheral blood lymphocytes were used as NK effector ce

295 The recipients' peripheral-blood lymphocytes were collected before myelo

296 , 2, 6.2, 11, and 19 as compared to unprimed peripheral blood lymphocytes, whereas the usage of other

297 evels of genotoxicity following treatment of peripheral blood lymphocytes with complex 9, suggesting

298 as the correlations of tetramer staining of peripheral blood lymphocytes with CTL killing in vitro a

299 AD(+) levels were increased by supplementing peripheral blood lymphocytes with the NAD(+) precursors

300 ayed a dose-dependent, reversible decline in peripheral blood lymphocytes without an enhanced inciden